Detailed phytochemical characterization and bioactive properties of: Myrtus nivelii Batt & Trab by Rached, Wahiba et al.
Food &
Function
PAPER
Cite this: Food Funct., 2017, 8, 3111
Received 19th May 2017,
Accepted 10th July 2017
DOI: 10.1039/c7fo00744b
rsc.li/food-function
Detailed phytochemical characterization and
bioactive properties of Myrtus nivelii Batt & Trab
Wahiba Rached,a,b,c,d Malika Bennaceur,a,e Lillian Barros, *b Ricardo C. Calhelha,b
Sandrina Heleno, b,f Maria José Alves,b Ana Maria Carvalho,b Abderrazak Maroufe
and Isabel C. F. R. Ferreira *b
The endemic Algerian myrtle, Myrtus nivelii Batt & Trab., was evaluated for its bioactive properties, such as
antioxidant, anti-inﬂammatory, cytotoxic and antibacterial activities, and correlated with the individual
phenolic compounds identiﬁed in its crude aqueous extract and subsequent organic fractions (ethyl
acetate and butanol). Flavonols, such as myricetin, kaempferol and quercetin glycoside derivatives, were
the major phenolic compounds found, along with the presence of ellagitannins. The ethyl acetate fraction
contained the highest amount of phenolic compounds, followed by the butanol fraction and, ﬁnally, the
crude aqueous extract. In general, all samples exhibited an excellent bioactivity, namely the ethyl acetate
fraction that presented strong antioxidant activity, when compared to the standard trolox, strong cyto-
toxicity and antibacterial activity, especially against MRSA and MSSA. The present study revealed that the
ethyl acetate fraction of M. nivelii could be used as a source of bioactive compounds in the food and
pharmaceutical industries.
1. Introduction
Plants are able to produce a great number of secondary metab-
olites, among them are terpenoids, alkaloids and phenolic
compounds. These last molecules, mainly flavonoids, phenolic
acids, lignans, tannins and stilbenes, are very common in
diﬀerent plant parts, and widely exploited and used in the
food, cosmetic and pharmaceutical industries. Phenolic com-
pounds are not only present in the most commonly consumed
products, such as fruits and vegetables, but they are also
present in medicinal herbs.1 Polyphenols are widely studied in
the medicinal field, where they are recognized for their bio-
activities, such as antioxidant, anti-inflammatory2 and anti-
fungal3 activities. They also have positive eﬀects on obesity4 and
cancer.5 In particular, these molecules are strong inhibitors of
oxidative stress, hence they contribute to reactive oxygen
species (ROS) scavenging,6 preventing oxidation eﬀects by acti-
vating the endogenous antioxidant defense system,7 and also
protecting against the lipid oxidation phenomenon, which is
responsible for the development of oxidative diseases.6
Moreover, phenolic compounds, such as phenolic acids, flavo-
noids and tannins, have been isolated from diﬀerent plant
sources and have inhibited various pathogenic bacteria8 and
fungi.3
Myrtaceae is a widespread plant family in the
Mediterranean area, especially in Algeria, where a great
number of species from the genus of this family can be found.
In this family, there are numerous endemic species that are
used in traditional therapy, in order to cure or prevent a
diverse number of pathologies.2,9 These bioactivities have been
correlated with a wide variety of secondary metabolites, such
as hydroxybenzoic acid derivatives and flavonoids.9
The Myrtus herba commonly named Myrtle is considered
the most famous genus used to treat diabetes, hypertension
and respiratory tract diseases.10 This is due to the presence of
bioactive compounds with innumerous biological activities
reported in the literature such as antioxidant, hypotensive,
antimicrobial, anti-inflammatory, hypoglycemic, and anti-
cancer activities.11 The most abundant compounds present in
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these species, mostly in the leaves, are phenolic compounds,
such as flavonoids (myrecitin and quercetin glycoside
derivatives, and flavan-3-ol derivatives) and phenolic acids
(gallic, caﬀeic and ellagic acids).10
In Algeria, there are two characteristic species of Myrtle:
Myrtle communis L., the most known and common species in
the Mediterranean area, being more abundant in the north of
Algeria; and Myrtus nivelii Batt. & Trab., which is found in the
desert, in the south of Algeria, and is much less explored. The
common name of this species is Saharan myrtle (Rihan
Esahraa in Algerian), an endemic plant found in the moun-
tains (in altitude above 1500 to 2000 m), in the central Sahara,
being widespread in the Hoggar and Tassili N’Ajjer mountains
in Algeria, the Tibesti mountains in Chad and Lybia. This
plant species is well known in southern Algeria for its thera-
peutic properties; its leaves are collected throughout the year
and prepared as decoctions that are taken orally for the treat-
ment of liver problems, gastrointestinal disorders, diarrhea,
fever, diabetes, respiratory infections, rheumatism, allergies,
and fungal infections,12 while leaf infusions also used against
blennorrhea. The antioxidant, antimicrobial and anti-inflam-
matory activities of aqueous and methanol extracts obtained
from M. nivelii were previously reported,13–15 but only corre-
lated with total compounds,15 without a clear identification of
individual bioactive molecules.
The aim of the present work was to investigate the individ-
ual phenolic compounds of Myrtus nivelii Batt. & Trab. (crude
aqueous extract, and acetyl acetate and butanol fractions), as
well as to evaluate its biological activities (antioxidant, cyto-
toxic, anti-inflammatory and antibacterial).
2. Materials and methods
2.1. Plant material
The leaves of Myrtus nivelii Batt & Trab. (Saharan myrtle; local
name: “Targui”: tafeltest and “arabe”: rihan Sahraa) were col-
lected at Tamanrasset (south of Algeria) in November 2013.
The taxonomic identification of the plant material was con-
firmed by Dr Rabéa Sahki, researcher in the National Institute
for Forest Research of Tamanrasset, Algeria.
The plant material was dried under air circulation con-
ditions (oven-dried at 40 °C for 48 h) and then ground to a fine
powder (∼40 mesh).
2.2. Standards and reagents
HPLC-grade acetonitrile and ethyl acetate (99.8%) were from
Fisher Scientific (Lisbon, Portugal). Butanol (99%) was from
Lab-Scan analytical sciences (Gliwice, Germany). Trolox
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid),
acetic acid, formic acid, ellipticine, sulforhodamine B (SRB),
trypan blue, trichloroacetic acid (TCA) and Tris were purchased
from Sigma-Aldrich (St Louis, MO, USA). Phenolic compound
standards were purchased from Extrasynthèse (Genay, France).
2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained from Alfa
Aesar (Ward Hill, MA, USA). Foetal bovine serum (FBS),
L-glutamine, Hank’s balanced salt solution (HBSS), trypsin-
EDTA (ethylenediaminetetraacetic acid), penicillin/strepto-
mycin solution (100 U mL−1 and 100 mg mL−1, respectively),
RPMI-1640 and DMEM media were from Hyclone (Logan,
Utah, USA). The culture media Muller Hinton Broth (MHB)
and Tryptic Soy Broth (TSB) were obtained from Biomerieux
(Marcy l’Etoile, France), as well as the blood agar with 7%
sheep blood and Mac Conkey agar plates. The dye p-iodonitro-
tetrazolium chloride (INT) was purchased from Sigma-Aldrich
(St Louis, MO, USA) and it was used as a microbial growth
indicator. The water was treated in a Milli-Q water purification
system (TGI Pure Water Systems, Greenville, SC, USA).
2.3. Extraction procedure
The crude aqueous extract of M. nivelii was obtained under
heat reflux extraction with distilled water 10% (w/v) for 30 min,
three times. Subsequently, each extract was filtered and lyophi-
lized (Gardiner, NY, USA) to dryness. The obtained lyophilized
extracts were solubilized in distilled water (100 mL) and suc-
cessive partitions were performed by liquid–liquid extraction
by using increasing polarity solvents (chloroform, ethyl acetate
and n-butanol). The crude aqueous extract and its ethyl acetate
and butanol fractions were used in the subsequent assays. The
crude aqueous extract and fractions were dissolved in water
and water/methanol (80 : 20, v : v), respectively, at 5 mg mL−1,
in order to obtain the phenolic compounds profile; water and
methanol, respectively (5 mg mL−1), for antioxidant activity
evaluation; in the medium (20 mg mL−1) for antibacterial
assays; and in water (8 mg mL−1) for anti-inflammatory and
cytotoxicity tests. For bioactivity evaluation assays, the stock
solutions were further diluted and tested.
2.4. Phenolic compounds’ characterization
The phenolic compounds profile was determined by using an
LC-DAD-ESI/MSn (Dionex Ultimate 3000 UPLC, Thermo
Scientific, San Jose, CA, USA), as previously described by
Bessada et al.16 For the double online detection, 280 and
370 nm were used as the preferred wavelengths for DAD and in
a mass spectrometer (MS). MS detection was performed in
negative mode, using a Linear Ion Trap LTQ XL mass spectro-
meter (ThermoFinnigan, San Jose, CA, USA) equipped with an
ESI source. The identification of the phenolic compounds was
performed using standard compounds, when available, by
comparing their retention times, UV-vis and mass spectra; and
also, comparing the obtained information with available data
reported in the literature giving a tentative identification. For
quantitative analysis, a calibration curve for each available phe-
nolic standard was constructed based on the UV signal. For
the identified phenolic compounds for which a commercial
standard was not available, the quantification was performed
through the calibration curve of the most similar available
standard. The results were expressed as mg g−1 of the extract.
2.5. In vitro antioxidant activity assays
The antioxidant activity was assessed by using four diﬀerent
methodologies, DPPH radical-scavenging, reducing power,
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inhibition of β-carotene bleaching and TBARS inhibition
assays.17 The results were expressed as EC50 values (μg mL−1),
sample concentration providing 50% of antioxidant activity or
0.5 of absorbance in the reducing power assay. Trolox was
used as the positive control.
2.6. In vitro anti-inflammatory assays
The evaluation of the anti-inflammatory properties was per-
formed according to the previously described method by
Sobral et al.18 For the determination of nitric oxide, a Griess
Reagent System kit was used, which contains sulfanilamide,
NED and nitrite solutions. The nitrite produced was deter-
mined by measuring the optical density at 515 nm, using an
ELX800 microplate reader (Bio-Tek Instruments, Inc;
Winooski, VT, USA) and was compared to the standard cali-
bration curve. The results were expressed in percentages of
inhibition of NO production in comparison with the negative
control (100%) and EC50 values (sample concentration provid-
ing 50% of inhibition of NO production) were also estimated.
Dexamethasone was used as the positive control.
2.7. Cytotoxicity assays
Four human tumor cell lines were tested: MCF-7 (breast adeno-
carcinoma), NCIH460 (non-small cell lung carcinoma), HeLa
(cervical carcinoma) and HepG2 (hepatocellular carcinoma).
Sulforhodamine B assay was performed according to a pro-
cedure previously described by the authors, Barros et al.17 For
evaluation of the cytotoxicity in non-tumor cells, a cell culture
(assigned as PLP2) was prepared from a freshly harvested
porcine liver obtained from a local slaughterhouse, according
to a procedure established by the authors, Abreu et al.;19 ellip-
ticine was used as the positive control and the results were
expressed in GI50 values (concentration that inhibited 50% of
the net cell growth).
2.8. Antibacterial activity
The antibacterial activity was evaluated against clinical isolates
obtained from patients hospitalized in the Local Health Unit
of Bragança and Hospital Centre of Trás-os-Montes and Alto-
Douro-Vila Real, Northeast of Portugal. The bacterial strains
studied were six Gram-negative bacteria (Escherichia coli, E. coli
ESBL, Klebsiella pneumoniae and K. pneumonia ESBL,
Morganella morganii, and Pseudomonas aeruginosa), and four
Gram-positive bacteria (MRSA – methicillin-resistant
Staphylococcus aureus, MSSA – methicillin-susceptible
Staphylococcus aureus, Listeria monocytogenes and Enterococcus
faecalis). MIC determinations were performed by the micro-
dilution method using the p-iodonitrotetrazolium chloride
(INT) colorimetric assay according to Dias et al.20 MBC concen-
trations were calculated by adding 10 µL of the MIC and
higher concentrations to fresh culture medium to see if the
bacteria were able to grow. After 24 h of incubation at 37 °C,
the bactericidal concentrations were registered. The antibiotic
susceptibility profile of Gram-negative and Gram-positive bac-
teria was previously described by Dias et al.20
2.9. Statistical analysis
Three crude extracts and three of each one of the fractions
were used and all assays were performed in triplicate. The
results were expressed as mean values and standard deviations
(SD). The results obtained were analyzed using one-way ana-
lysis of variance (ANOVA) followed by Tukey’s HSD test with
α = 0.05. In the case of phenolic composition, a Student’s t-test
was also used to determine significant diﬀerences when the
number of cases for a determined condition was less than 3,
with α = 0.05. This treatment was carried out using the
SPSS v. 23.0 program (IBM Corp., Armonk, New York, USA).
3. Results and discussion
3.1. Phenolic compounds
The characterization of phenolic compounds in M. nivelii
crude aqueous extract and acetyl acetate and butanol fractions
is shown in Table 1, and an example of the profile is presented
in Fig. 1. To the authors’ best knowledge, this is the first
report on the identification and quantification of individual
phenolic compounds present in M. nivelii. Twenty-seven
diﬀerent compounds were identified, comprising hydrolysable
tannins (gallotannin and ellagitannin derivatives), flavonoids
(myricetin, quercetin, kaempferol and catechin derivatives)
and a phenolic acid (ellagic acid). The ethyl acetate fraction
revealed the presence of 25 compounds (Fig. 1), while the
butanol fraction and the crude aqueous extract revealed only
19 and 17 compounds, respectively.
Peaks 1, 2, 4, 5, 7, 9, 10, 14, 16 and 18 showed UV spectra
coherent with galloyl hexahydroxydiphenoyl (HHDP) deriva-
tives (peaks 1, 2, 4, 7, 10 and 14) or gallotannins composed of
trimeric and tetrameric galloyl moieties linked to glucose
(peaks 5, 9, 16 and 18). According to the literature, the main
characteristic in the mass spectra of these compounds is the
deprotonated molecule [M − H]− and the loss of one or more
gallic acid (170 mu) and/or galloyl groups (152 mu).21 Mass
characteristics of peaks 1 and 2 ([M − H]− at m/z 633; fragment
ions at m/z 463 and 301) coincided with a galloyl-HHDP-
glucose, whereas peaks 4, 7 and 10 ([M − H]− at m/z 785; frag-
ment ions at m/z 633, 615, 483, 419, 301) correspond to digal-
loyl-HHDP-glucoside, while peak 14 ([M − H]− at m/z 937; frag-
ment ions at m/z 767, 635, 465 and 301) was coherent with a
trigalloyl-HHDP-glucose.22 Compounds 5 and 9 (the [M − H]−
ion at m/z 635) revealed a typical fragmentation pattern of a tri-
galloylglucoside, while compounds 16 and 18 (the [M − H]−
ion at m/z 787) presented a fragmentation pattern character-
istic of tetragalloylglucoside.21
Peak 3 ([M − H]− at m/z 495) was identified as digalloylqui-
nic acid, releasing three MS2 fragment ions at m/z 343 (release
of the first galloyl group [M − 152-H]−), m/z 191 (release of the
second galloyl group [M − 152-H]−) and m/z 169 (release of the
quinic acid with the formation of the deprotonated gallic
acid).23 Similarly, peak 8 ([M − H]− at m/z 647) was identified
as trigalloylquinic acid. Peak 12 ([M − H]− at m/z 469) was
identified as a valoneic acid dilactone, taking into account the
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Table 1 Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, identiﬁcation and quantiﬁcation of phenolic compounds in M. nivelii leaves
(mean ± SD)
Peak
Rt
(min)
λmax
(nm)
[M − H]−
(m/z) MS2 (m/z) Tentative identification
Quantification (mg g−1 extract)
Student’s
t-test
Crude aqueous
extract
Ethyl acetate
fraction
Butanol
fraction
1 4.43 267 633 463(100), 301(62) Galloyl-HHDP-glucoside1 nd nd 10.1 ± 0.4 —
2 5.09 266 633 463(100), 301(51) Galloyl-HHDP-glucoside1 29.0 ± 0.5 nd 17.4 ± 0.2 <0.001
3 5.32 273 495 343(00), 191(86), 169(60) Digalloylquinic acid2 nd 6.41 ± 0.07 14.3 ± 0.2 <0.001
4 5.63 274 785 633(38), 615(23), 483(93), 419(21), 301(100) Digalloyl-HHDP-glucoside1 14.5 ± 0.2c 19.28 ± 0.08b 26.7 ± 0.3a —
5 6.5 269 635 483(19), 465(100), 421(80), 313(52), 295(28), 169(32) Trigalloylglucoside2 3.0 ± 0.2c 7.1 ± 0.8a 6.18 ± 0.05b —
6 6.85 256 953 909(5), 785(50), 765(15), 633(100), 615(3),
483(53), 419(10), 301(20)
Rugosin B1 5.4 ± 0.1c 7.0 ± 0.7b 9.4 ± 0.2a —
7 7.77 265 785 633(21), 615(8), 483(100), 419(12), 301(72) Digalloyl-HHDP-glucoside1 8.9 ± 0.1c 20.72 ± 0.02a 16.9 ± 0.4b —
8 8.67 276 647 495(100), 477(18), 343(80), 325(43), 191(20),
173(13), 169(47)
Trigalloylquinic acid2 11.2 ± 0.2c 22.2 ± 0.3b 31.3 ± 0.2a —
9 9.9 276 635 483(18), 465(100), 421(6), 313(80), 295(12), 169(24) Trigalloylglucoside2 nd 12.3 ± 0.1 12.2 ± 0.3 0.589
10 10.23 270 785 633(17), 615(12), 483(99), 419(18), 301(100) Digalloyl-HHDP-glucoside2 7.22 ± 0.02b 11.1 ± 0.3a 6.6 ± 0.2c —
11 10.61 273 915 457(100), 331(58), 305(26), 169(98) Gallocatechin-gallate-dimer3 10.9 ± 0.2c 35.6 ± 0.4a 13.2 ± 0.2b —
12 12.6 258 364 469 425(100), 301(75) Valoneic acid dilactone1 nd 9.5 ± 0.2 8.47 ± 0.01 0.005
13 14.04 356 631 479(100), 317(63) Myricetin-hexosyl-gallate4 13.4 ± 0.2c 37.0 ± 0.5a 17.8 ± 0.1b —
14 14.78 276 937 767(100), 635(17), 465(56), 301(37) Trigalloyl-HHDP-glucoside1 4.63 ± 0.05 17.1 ± 0.4 nd <0.001
15 15.15 357 479 317(100) Myricetin-3-O-glucoside4 8.48 ± 0.09c 19.88 ± 0.05b 23.6 ± 0.3a —
16 15.5 273 787 635(27), 617(100), 301(15) Tetragalloylglucose1 nd 16.3 ± 0.1 nd —
17 16.01 260 1105 1061(100), 937(87), 785(29), 767(84), 635(14), 465(61),
419(21), 301(41)
Rugosin A1 4.9 ± 0.2c 9.7 ± 0.1a 7.8 ± 0.2b —
18 16.4 277 787 635(15), 617(100), 301(25) Tetragalloylglucose1 4.02 ± 0.02 13.2 ± 0.5 nd <0.001
19 17.13 352 615 463(100), 301(66) Quercetin-hexosyl-gallate5 1.88 ± 0.08c 10.54 ± 0.06a 1.99 ± 0.04b —
20 17.83 356 463 317(100) Myricetin-3-O-rhamnoside4 11.3 ± 0.4c 85.75 ± 0.03a 12.4 ± 0.1b —
21 18.75 354 463 301(100) Quercetin-3-O-glucoside5 1.64 ± 0.02c 3.1 ± 0.2a 2.18 ± 0.02b —
22 19.17 251 366 301 284(15), 245(20), 185(12), 173(5), 157(3) Ellagic acid1 nd 27.1 ± 0.1 6.4 ± 0.4 <0.001
23 19.61 356 599 447(100), 285(28) Kaempferol-hexosyl-gallate6 4.3 ± 0.4 8.34 ± 0.07 nd <0.001
24 21.52 351 447 285(100) Kaempferol-3-O-glucoside6 nd 3.3 ± 0.1 nd —
25 22.8 348 447 301(100) Quercetin-3-O-rhamnoside5 nd 3.2 ± 0.2 nd —
26 25.05 370 317 299(18), 289(29), 273(12), 245(14) Myricetin4 nd 5.5 ± 0.1 nd —
27 27.93 316 625 479(100), 317(32) Myricetin-coumaroylhexoside4 nd 2.12 ± 0.04 nd —
Total hydrosable tannins 93 ± 1c 172 ± 1a 167.5 ± 0.4b —
Total phenolic acids — 27.08 ± 0.08 6.4 ± 0.4 <0.001
Total flavonoids 45 ± 1c 200 ± 2a 62.9 ± 0.7b —
Total phenolic compounds 138 ± 3c 398 ± 3a 236.8 ± 0.1b —
nd – not detected. Standard calibration curves: (1) ellagic acid (y = 26719x − 317 255, R2 = 0.9986); (2) gallic acid (y = 208604x + 173 056, R2 = 0.9999); (3) catechin (y = 84950x − 23 200,
R2 = 0.9999); (4) myricetin-3-O-glucoside (y = 23287x − 581 708, R2 = 0.9988); (5) quercetin-3-O-glucoside (y = 34843x − 160 173, R2 = 0.9998); (6) kaempferol-3-O-glucoside (y = 11117x + 30 861,
R2 = 0.9999). In each row, diﬀerent letters mean significant diﬀerences between M. nivelii extract and fractions (p < 0.05). When only two samples were present a Student’s t-test was used to
determine the significant diﬀerence between two diﬀerent samples, with α = 0.05.
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fragmentation pattern and UV-Vis spectra presented in ref. 23.
Similarly, peaks 6 ([M − H]− at m/z 953) and 17 ([M − H]− at
m/z 1105) were identified as rugosins A and B, respectively,
taking into account all the MS characteristics discussed by the
author Fecka.24
Compound 22 (ellagic acid) was positively identified accord-
ing to its retention, mass and UV-vis characteristics by com-
parison with a commercial standard.
The remaining compounds correspond to flavonols (peaks
13, 15, 19–21, 23–27) and to one flavan-3-ol (peak 11). This last
peak ([M − H]− at m/z 915) was tentatively identified as a
dimer of gallocatechin-gallate, presenting a fragment pattern
with the fragments at m/z 457 (gallocatechin-gallate) and m/z
169 (gallate), previously reported by Fracassetti et al.25 The
detected flavonols were derived from quercetin (λmax around
350 nm, MS2 fragment at m/z 301), kaempferol (λmax around
348 nm, MS2 fragment at m/z 285) and myricetin (λmax around
354 nm, MS2 fragment at m/z 317) (Table 1). Myricetin-3-O-glu-
coside (peak 15), quercetin-3-O-glucoside (peak 21), kaemp-
ferol-3-O-glucoside (peak 24) and myricetin (peak 26) were
positively identified according to their retention, mass and
UV-vis characteristics by comparison with commercial stan-
dards. The flavonoid myricetin-3-O-glucoside has been pre-
viously reported in the leaves of Myrtus communis L.11,26
Compounds 20 ([M − H]− at m/z 463) and 25 ([M − H]− at m/z
447) presented an MS2 fragment at m/z 317 (myricetin) and m/z
301 (quercetin) corresponding to the loss of a rhamnosyl
(−146 mu) moiety. These compounds were assumed as myrice-
tin-3-O-rhamnoside and quercetin-3-O-rhamnoside, due to
their previous identification in the leaves of M. communis by
Romani et al.27 and Messaoud et al.11 Furthermore, peaks 13,
19 and 23 were identified as hexosyl derivatives of myricetin,
quercetin and kaempferol that also appeared to be attached to
a gallic acid moiety, yielding deprotonated ions at m/z 631
(peak 13), consistent with myricetin-hexosyl-gallate, m/z 615
(peak 19) with quercetin-hexosyl-gallate, and m/z 599 (peak 23)
with kaempferol-hexosyl-gallate. Finally, peak 27 ([M − H]− at
m/z 625) was identified as a myricetin-coumaroylhexoside, due
to the fragmentation of the product ion at m/z 479 (loss of the
p-coumaroyl residue, −146 u) and m/z 317 (loss of the hexosyl
moiety). This peak was identified as a flavonol glycoside linked
to a phenolic acid due to its late elution time, since the pres-
ence of the hydroxycinnamoyl residue implies a decrease in
polarity, as also due to its UV-Vis spectra (λmax 316 nm).
The highest phenolic content was found in the ethyl acetate
fraction (398 mg g−1 of extract, Table 1), myricetin glycoside
derivatives being the most abundant compounds (total of
136 mg g−1), especially myricetin-3-O-rhamnoside and myrice-
tin-hexosyl-gallate, respectively. These derivatives accounted
for 34% of the total phenolic compounds in this fraction and
were three fold higher than that in the butanol fraction
(46 mg g−1) and four fold higher than that in the crude extract
(26 mg g−1). The compound gallocatechin gallate was also
mainly present in the ethyl acetate fraction (35.6 mg g−1),
being three times higher than the one in the crude aqueous
extract (10.9 mg g−1) and in its butanol fraction (13.2 mg g−1).
Hydrolysable tannins were also relevant constituents in all
samples, although presenting a higher concentration in the
ethyl acetate fraction (172 mg g−1, Table 1). Nevertheless, this
fraction did not reveal the presence of galloyl-HHDP-gluco-
sides (peaks 1 and 2), which were the most abundant com-
pounds in the crude aqueous extract, while trigalloylquinic
acid (peak 8) was the most abundant compound in the
butanol fraction and the most abundant hydrolysable tannin
in the ethyl acetate fraction.
The results obtained in this study showed that there are two
main groups of polyphenolic compounds in the studied
Algerian desert myrtle extracts: flavonols and hydrolysable
tannins. This is in agreement with previous studies on this
genus, especially on the leaves of M. communis, in which the
main phenolic compounds are also flavonols (myricetin 3-O-
galactoside, myricetin-3-O-rhamnoside and quercetin-3-O-gluco-
side), flavan-3-ols (catechin, gallocatechin and epigallocatechin)
and hydrolysable tannins.26,27
3.2. Antioxidant activity
The antioxidant activity was evaluated by using four method-
ologies, representing diﬀerent mechanisms, such as DPPH
radical scavenging activity, reducing power, β-carotene bleach-
ing inhibition and inhibition of lipid peroxidation through the
TBARS assay; the results are presented in Table 2. This genus
has been shown to have interesting antioxidant capacity,
which can be related to its antiproliferative properties, particu-
larly associated with the presence of flavonoids and hydrolysa-
ble tannins.27
The very low EC50 value presented by the ethyl acetate frac-
tion (3.27 µg mL−1) indicates the highest DPPH scavenging
activity, when compared to the butanol fraction and crude
Fig. 1 Phenolic compounds proﬁle of M. nivelii ethyl acetate fraction, recorded at 280 nm. Peak numbering corresponds to the molecules identiﬁed
in Table 1.
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aqueous extract (EC50 values of 4.6 and 7.1 µg mL
−1, respect-
ively). The reducing power methodology measures the ability
of an antioxidant to donate electrons to Fe(III) resulting in the
transformation of the Fe3+/ferricyanide complex to the Fe2+
complex. In fact, the extracts presented a great reducing power,
ranging from 3.14 to 6.22 µg mL−1. Once again, ethyl acetate
revealed the highest ability to reduce Fe(III) followed by the
butanol fraction and the crude aqueous extract. The β-carotene
bleaching inhibition method is based on the discoloration of
β-carotene due to its reaction with radicals, which are formed
by linoleic acid oxidation in an emulsion. The bleaching inhi-
bition of β-carotene can be delayed in the presence of anti-
oxidants which have the ability to neutralize free radicals and
inhibit the lipid peroxidation. All the extracts demonstrated
strong antioxidant properties, displaying that the ethyl acetate
fraction has the greatest inhibition eﬀect (3.30 µg mL−1), fol-
lowed by the butanol fraction (3.72 µg mL−1) and the crude
aqueous extract (4.49 µg mL−1). The capacity of the extracts to
inhibit the formation of the complex MDA-TBA (malondialde-
hyde-thiobarbituric acid) was measured using porcine brain
tissue homogenates (Table 2). All samples showed high
capacity against lipid peroxidation, the ethyl acetate fraction
again being the most eﬃcient when compared to the butanol
fraction and crude aqueous extract (EC50 values of 0.46, 0.74
and 0.87 µg mL−1, respectively).
Overall, the ethyl acetate fraction exhibited the highest anti-
oxidant activity, followed by the butanol fraction and the crude
aqueous extract in all the methods (Table 2). With the excep-
tion of β-carotene bleaching inhibition, all samples presented
higher antioxidant activity than the standard trolox (used as a
reference compound).
Moreover, the antioxidant activity presented by the two frac-
tions and by the crude aqueous extract could be correlated
with the phenolic composition, especially with flavonol and
hydrolysable tannin contents. These phenolic groups have
been previously reported to show a high antioxidant activity.28
The considerable higher levels of myricetin-hexosyl-gallate,
myricetin-3-O-rhamnoside, gallocatechin-gallate-dimer, digal-
loyl and trigaloyl-HHDP-glucoside, tetragalloylglucoside, and
of the quercetin and kaempferol derivatives, in the ethyle
acetate fraction (Table 1), may be considered the main factor
contributing to its higher antioxidant capacity. This is also in
accordance with the findings reported by several authors.29,30
Pereira et al.31 showed that myricetin-3-O-galactoside and myri-
cetin-3-O-rhamnoside isolated from M. communis demon-
strated a strong antioxidant activity. These results could also
confirm the highest antioxidant activity of the ethyl acetate in
comparison with the other fraction and with the crude extract.
In fact, many reports indicate the antioxidant eﬀect of poly-
phenolic components including myricetin, quercetin, kaemp-
ferol, catechin and their derivatives.32 Similarly, the relation-
ship between the antioxidant activity and phenolic content of
M. nivelii could also be established in this study.
3.3. Anti-inflammatory activity
Murine macrophage-like RAW 264.7 cells are commonly used
in anti-inflammatory response studies. Nitric oxide (NO) is an
important oxidative and inflammatory mediator produced by
macrophages and used as an indicator of inflammation
induced by LPS (lipopolysaccharide). Table 2 presents the
results obtained for the anti-inflammatory activity of the ethyl
and butanol fractions and of the crude aqueous extract. The
results reveal that all extracts suppressed the production of NO
with EC50 = 104, 127 and 149 µg mL
−1, for ethyl acetate and
butanol fractions and, finally, the crude aqueous extract,
respectively. The ethyl acetate fraction was the most active in
the suppression of NO, whereas the butanol fraction and the
crude aqueous extract reduced less the NO production. These
results were in agreement with Touaibia & Chaouch,14 who
demonstrated the anti-inflammatory eﬀectiveness, by the inhi-
bition of paw edema, of the methanol extract of M. nivelii by
using an in vivo test with carrageenan paw edema from male
Swiss mouse.
The NO inhibition potential of the extracts could be attribu-
ted to the presence of bioactive compounds like flavonols, ella-
gitanins and phenolic acids, the main molecules found in this
species, which are known for their in vivo and in vitro anti-
inflammatory eﬀect.33 The diﬀerences between the samples
Table 2 Antioxidant activity and NO formation inhibition capacity of M. nivelii leaves
Crude aqueous
extract
Ethyl acetate
fraction
Butanol
fraction
Positive
controla
Antioxidant activity(EC50values, µg mL
−1)
DPPH scavenging activity 7.1 ± 0.1a 3.27 ± 0.05c 4.6 ± 0.2b 42 ± 1
Reducing power 6.23 ± 0.04a 3.15 ± 0.01c 3.93 ± 0.03b 41 ± 1
β-Carotene bleaching inhibition 112 ± 3a 82 ± 2c 92.9 ± 0.2b 18 ± 1
TBARS inhibition 0.87 ± 0.02a 0.46 ± 0.02c 0.74 ± 0.06b 23 ± 1
Anti-inflammatory activity (EC50 values, µg mL
−1)
Nitric oxide (NO) production 149 ± 8a 104 ± 6c 127 ± 12b 16 ± 1
a Trolox and dexamethasone for antioxidant and anti-inflammatory activities, respectively. The antioxidant activity was expressed as EC50 values
(mean ± SD), which means that higher values correspond to lower reducing power or antioxidant potential. EC50: extract concentration corres-
ponding to 50% of antioxidant activity or 0.5 of absorbance in reducing power assay. The results of anti-inflammatory activity are expressed in
EC50 values: sample concentration providing 50% of inhibition of nitric oxide (NO) production. In each row, diﬀerent letters mean significant
diﬀerences between M. nivelii extract and fractions (p < 0.05).
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could be attributed to the diﬀerent biomolecules’ distribution
in fractions and crude extract.
3.4. Cytotoxic properties
The results of cytotoxicity of the crude extract and its fractions
are summarized in Table 3. All tested samples showed promis-
ing cytotoxic properties towards the selected tumor cell lines
(MCF-7, NCI-H460, HeLa and HepG2). The ethyl acetate frac-
tion showed a significant higher potential against all the
studied cell lines: MCF-7 (16.12 µg mL−1); NCI-H460 (49.01
µg mL−1); HeLa (15.39 µg mL−1) and HepG2 (17.67 µg mL−1),
followed by the butanol fraction and the crude aqueous
extract. However, all samples also presented toxicity eﬀects for
non-tumor cells, although the ethyl acetate presented the
lowest toxicity.
It has been previously reported that certain phenolic com-
pounds can contribute to the protection of cancer disease,
such as ellagic acid, ellagitannins and quercetin and its
derivatives.34–37 These compounds have exhibited antimuta-
genic and anticarcinogenic activity in vitro and in situ in
various human tumor cell lines, such as growth inhibition of
lung tumorigenesis in mice,37 anticarcinogenic eﬀects against
the colon tumor cell line HCT-11635 and antiproliferative
eﬀects of cervical carcinoma (Caski, HeLa and Siha cell
lines).36 Liberal et al.34 confirmed the cytotoxic potential of
ellagitannins on human hepatocellular carcinoma cells.
Therefore, the inhibition eﬀects exhibited by the studied
extracts are related to their contents in bioactive molecules,
which can be considered promising cytotoxic phytochemicals.
3.5. Antibacterial activity
The antibacterial activity of the crude aqueous extract and of
its two fractions is shown in Table 4. All extracts exhibited anti-
bacterial activity against the ten tested bacteria strains, with
minimal inhibitory concentrations (MICs) ranging between
0.078 and 10 mg mL−1. All extracts revealed an excellent anti-
bacterial activity and in a similar order to the other bioactiv-
ities mentioned above, ethyl acetate fraction > butanol fraction
> crude aqueous extract. MRSA and MSSA were the most sus-
ceptible Gram-positive bacteria, while E. coli and ESBL E. coli
were the most sensitive Gram-negative bacteria, for all tested
samples. It is important to highlight that all the samples pre-
sented strong bactericidal concentrations, especially against
MRSA and MSSA.
Nevertheless, the inhibition growth was higher with the
ethyl acetate fraction in comparison with the other samples
and this activity can be associated with the highest levels of
the majority of phenolic compounds present in this fraction.
Similarly, Mert et al.38 also tested the antibacterial potential of
M. communis, against E. coli, S. aureus, Enterococcus faecalis
and Pseudomonas aeruginosa by the disc diﬀusion method. In
this study, the ethyl acetate fraction also gave the strongest
activity against S. aureus. Quercetin-3-O-rhamnoside, isolated
from the ethyl acetate fraction of Anacardium occidentale
L. leaves, also revealed a good antimicrobial activity against all
studied strains (Escherichia coli ATCC 25922, Pseudomonas aer-
uginosa ATCC 27853, P. fluorescence NCIB 3756, Staphylococcus
aureus ATCC 29213, Bacillus subtilis NCIB 3610, Klebsiella pneu-
monia (clinical strain) and Clostridium sporogens NCIB 532).39
The combination between two isolated compounds, quercetin-
3-O-rutinoside and quercetin-3-O-rhamnoside, also revealed a
higher antimicrobial activity than all extracts, which confirms
Table 3 Cytotoxic properties of M. nivelii leaves in human tumor cell lines and non-tumor liver primary cells
Crude aqueous
extract
Ethyl acetate
fraction
Butanol
fraction Ellipticine
Human tumor cell lines (GI50 values. µg mL
−1)
MCF-7 (breast carcinoma) 29 ± 2a 16 ± 1b 30 ± 2a 0.91 ± 0.04
NCI-H460 (non-small cell lung cancer) 72 ± 4b 49 ± 3c 89 ± 7a 1.03 ± 0.09
HeLa (cervical carcinoma) 61 ± 5a 15 ± 1c 37 ± 3b 1.91 ± 0.06
HepG2 (hepatocellular carcinoma) 223 ± 19c 18 ± 1b 27 ± 2b 1.1 ± 0.2
Non-tumor cells (GI50 values. µg mL
−1)
PLP2 (porcine liver primary cells) 97 ± 6b 112 ± 3a 71 ± 5c 3.2 ± 0.7
GI50 values (mean ± SD) correspond to the sample concentration achieving 50% of growth inhibition in human tumor cell lines or in liver
primary culture PLP2. In each row, diﬀerent letters mean significant diﬀerences between M. nivelii extract and fractions (p < 0.05).
Table 4 Antibacterial activity of M. nivelii leaves
Bacterial strains
Crude
aqueous
extract
Ethyl acetate
fraction
Butanol
fraction
Gram-positive MIC/MBC (mg mL−1)
Enterococcus faecalis 5/20 1.25/2.5 5/10
Listeria monocytogenes 10/20 5/10 10/20
MSSA 0.625/1.25 0.078/0.156 0.078/0.156
MRSA 0.625/1.25 0.078/0.156 0.078/0.156
Gram-negative MIC/MBC (mg mL−1)
Escherichia coli 0.625/2.5 0.3125/0.625 0.625/1.25
E. coli ESBL 0.625/2.5 0.3125/0.625 0.625/1.25
Klebsiella pneumoniae 1.25/5 1.25/2.5 1.25/2.5
K. pneumoniae ESBL 1.25/5 1.25/2.5 1.25/2.5
Morganella morganii 1.25/5 0.625/1.25 0.625/1.25
Pseudomonas aeruginosa 10/20 2.5/5 5/10
MRSA – methicillin resistant Staphylococcus aureus; MSSA – methicillin
susceptible S. aureus; MIC – minimal inhibitory concentration; MBC –
minimal bactericidal concentration; ESBL – spectrum extended
producer of β-lactamases.
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the synergistic eﬀect of these two compounds.39 Ellagitannins
have been also reported to present high antimicrobial
activity,40 which can explain the high antibacterial potential of
the herein studied samples.
Overall, the diﬀerences found in the bioactive properties of
the aqueous extract and the organic fractions can be related to
the diﬀerent profiles and quantities of phenolic compounds
present in each sample. To the authors’ best knowledge, the
current study is the first report on the individual phenolic
profile of M. nivelii leaves and evaluation of antioxidant, anti-
inflammatory, cytotoxic and antibacterial activities. The
present study also confirms the traditional medicinal use of
M. nivelii, highlighting the bioactive potential of ellagitannin
and flavonoid derivatives.
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